Emergence of Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus within 48 Hours
Authors:
- Timothy BarkhamTBTimothy Barkham
- Yee-Sin LeoYLYee-Sin Leo
- Kwai-Peng ChanKCKwai-Peng Chan
- Angela ChowACAngela Chow
- Christopher W. WongCWChristopher W. Wong
- Raphael Tze-Chuen LeeRLRaphael Tze-Chuen Lee
- Sebastian Maurer-StrohSMSebastian Maurer-Stroh
- Raymond LinRLRaymond Lin
- Cui LinCLCui Lin
Open Access
- 1 October 2010
- journal article
- case report
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 16 (10) , 1633-1636
Abstract
An oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus evolved and emerged from zero to 52% of detectable virus within 48 hours of a patient’s exposure to oseltamivir. Phylogenetic analysis and data gathered by pyrosequencing and cloning directly on clinical samples suggest that the mutant emerged de novo.Keywords
This publication has 13 references indexed in Scilit:
- Oseltamivir Resistance in Adult Oncology and Hematology Patients Infected with Pandemic (H1N1) 2009 Virus, AustraliaEmerging Infectious Diseases, 2010
- Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir ResistanceScience, 2010
- Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infectionJournal of Clinical Virology, 2010
- A Community Cluster of Oseltamivir-Resistant Cases of 2009 H1N1 InfluenzaNew England Journal of Medicine, 2010
- Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysisBMJ, 2009
- Critically Ill Patients With 2009 Influenza A(H1N1) in MexicoJAMA, 2009
- Influenza Virus Resistance to Antiviral Agents: A Plea for Rational UseClinical Infectious Diseases, 2009
- Global Transmission of Oseltamivir-Resistant InfluenzaNew England Journal of Medicine, 2009
- Use of oseltamivir in 12 European countries between 2002 and 2007 – lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) virusesEurosurveillance, 2009
- Antiviral Therapy and Outcomes of Influenza Requiring Hospitalization in Ontario, CanadaClinical Infectious Diseases, 2007